Corporate venture capital has become one of the most useful funding routes for UK founders who want more than a cheque from their investor.
Below is a working guide to the UK corporate venture capital arms currently active and verifiable what they invest, how much they write in, and what they expect in return, alongside honest notes on a couple of high-profile names that don't fit the brief as cleanly as their reputation suggests.
Quick reference:
What Corporate VC Actually Offers Founders
Corporate venture capital gives founders capital plus direct access to the parent company's infrastructure, customers, and expertise, something a traditional VC fund simply can't offer. Where a financial VC's only asset is capital and network, a corporate venture capital arm can hand a founder a route into a FTSE-listed customer base, a live R&D facility, or a regulated market the startup couldn't crack alone.
Shell Ventures, for instance, doesn't just write cheques; it offers portfolio companies access to technical and scientific expertise, R&D facilities, and field trial pilots, plus Shell's own global customer base and supplier network. That's the trade at the heart of every CVC investment: strategic alignment in exchange for capital that also happens to open doors.
The Arms: Ticket Sizes and Focus Areas
Shell Ventures typically writes an initial cheque of $2–5m, with total investment reaching up to $10–25m across a portfolio company's lifecycle. Founded in 1996 as one of the energy sector's first corporate venturing units, it focuses on power, mobility, emission management, resources and digital renewables, EV and transport tech, and data applications for energy. It's backed more than 50 companies to date, including two unicorns.
HSBC Ventures, HSBC's in-house emerging technology and innovation team, targets Artificial Intelligence, Digital Assets, Quantum Computing, Embedded Finance, Data Analytics and Sustainability. Third-party listings put its typical ticket at €100,000 to €1.5 million across pre-seed to late stage, a figure worth treating as indicative rather than confirmed, since HSBC hasn't published it directly. Portfolio names include blockchain analytics firm Elliptic.
Unilever Ventures is one of the longest-running corporate venture capital firms on this list, founded in 2002 and still active with more than 130 investments across 24 years. Ticket sizes run from $500K to $15M, concentrated at seed through Series A, with three current pillars: Beauty & Wellness, commerce technology, and B2B/enterprise solutions. Six unicorns and a $175m T-Mobile acquisition (Blis, March 2025) sit in its track record.
National Grid Partners has deployed more than $500 million since its 2018 founding, including a $100 million commitment dedicated to AI investments, as it continues to expand its focus on grid digitalisation and emerging technologies. It's US-headquartered but runs a genuinely trans-Atlantic remit, with London offices and 8 UK investments among its 48-company portfolio. Focus areas: decarbonisation, decentralisation and digitalisation of the energy grid AI, IoT, smart grid tech and security.
Aviva Ventures launched in 2016 with an initial $125 million commitment, later topped up by a further $185.5 million, targeting AI, cleantech, data and analytics, fintech and insurtech. Worth flagging for founders researching this one: Aviva Ventures was folded into Aviva Investors in 2025, which has since launched a new £150m evergreen venture fund with a UK bias so the "Aviva Ventures" brand is mid-transition, not static.
Legal & General Capital operates differently to the rest of this list, and founders should know that before pitching. It's largely a fund-of-funds vehicle, backing established UK VC funds like Balderton Capital and LocalGlobe rather than writing direct cheques to startups so it's not a straightforward CVC to approach cold with a deck.
Two other well-known names deserve an honest mention rather than a fabricated ticket size. Google for Startups UK runs a genuinely useful accelerator, but it's explicitly equity-free, no CVC investment changes hands, only cloud credits and mentoring. BT Ventures, despite the name, doesn't appear to operate as a disclosed CVC fund with a published ticket size; BT's startup engagement has instead run through scouting partnerships, such as its 2020 tie-up with accelerator Plug and Play.
What Each Wants Beyond the Investment
Every corporate venture capital arm on this list wants strategic value that outlasts the exit, not just a financial return:
Shell Ventures — scientific expertise, R&D facilities, and field-trial infrastructure for portfolio companies to test at scale.
Unilever Ventures — access to Unilever's global distribution and retail relationships, with an implicit acquisition pathway for the strongest performers.
National Grid Partners — a route to commercial partnership, with many portfolio companies going on to strike commercial agreements with National Grid's operating business.
HSBC Ventures — proximity to a regulated financial services environment for fintech and digital-asset startups to pilot within.
Aviva Ventures — insurtech and fintech founders get a live insurance distribution partner, not just capital.
The pattern holds across corporate venture capital firms generally: the cheque buys the corporate a seat at the table, and the founder gets access to infrastructure a Series A round from a traditional fund simply can't provide.
Corporate VC vs Traditional VC
The core difference between corporate venture capital and traditional VC is who's providing the capital and why. A traditional VC fund raises money from outside limited partners and is judged purely on financial return; a corporate venture capital arm is usually funded solely by its parent company and weighs strategic fit alongside sometimes above pure returns.
That changes the founder's calculus. Traditional VCs bring board experience and a fundraising network; CVC investment brings distribution, R&D access, and a potential buyer already sat at the table. Founders taking corporate money should expect slower decision cycles in exchange for that strategic depth and should read the small print on any acquisition option, as included in some historic corporate venturing deals.
How to Approach Them
Founders approaching a corporate venture capital arm should lead with strategic fit, not just growth metrics these investors are filtering for relevance to the parent's roadmap as much as for return. Research the specific unit's stated focus areas before reaching out; a pitch to Shell Ventures about power and mobility technology lands very differently to a generic climate-tech deck.
Where the CVC (like Legal & General Capital) mainly backs other funds rather than founders directly, save the pitch and target its portfolio VCs instead. And where a "venture" programme turns out to be equity-free, like Google for Startups UK, treat it as a resourcing opportunity rather than a funding round.
FAQs
1. What is corporate venture capital?
Corporate venture capital is when an operating company rather than a traditional VC firm invests directly in startups, usually as the sole backer, seeking both financial return and strategic value such as new technology or future partnership.
2. Which UK corporations have venture arms?
Verified, currently active corporate venture capital firms include Shell (Shell Ventures), HSBC (HSBC Ventures), Unilever (Unilever Ventures), National Grid (National Grid Partners), and Aviva (Aviva Ventures, now transitioning into Aviva Investors). Legal & General Capital also invests but mainly into other VC funds rather than startups directly.
3. What do corporate VCs want beyond a cheque?
Corporate VCs want strategic alignment that survives the exit access to the parent's customers, infrastructure, or R&D, and often a route toward a commercial partnership or eventual acquisition, as seen with National Grid Partners and Unilever Ventures.
Also read: What Is Vertical SaaS and Why UK VCs Love It?
Sources: Company disclosures from Shell, HSBC, Unilever, National Grid and Aviva; Tracxn and PitchBook investor profiles; Global Venturing reporting on Aviva Investors' 2025 fund restructuring and BT's startup partnerships.
The EP+ Editorial Desk covers UK startups, funding, and venture capital. All editorial content is independently produced and human-reviewed before publication
